CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline XPO Q1 2026 Earnings Earnings Surpass Estimates as Profitability Improves CNH Industrial Q1 2026 Earnings Modest EPS Beat Fails to Lift Sentiment ARE Q1 2026 Earnings Massive EPS Surprise Driven by Strong Operational Performance AMWD Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction OFS Q1 2026 Earnings Staggering EPS Beat of 475 Surprises Market